Floatz logo

Therapeutic Asset Ratings

13,150 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trastuzumab
Cervical Carcinoma
National Cancer Institute (NCI)P2B (56)
Trastuzumab
Colorectal Cancer
Fate TherapeuticsP2B (56)
Trastuzumab
Prostate Cancer
Mayo ClinicP2B (56)
Trastuzumab Deruxtecan
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P2B (56)
Trastuzumab Deruxtecan
Invasive Breast Carcinoma
National Cancer Institute (NCI)P2B (56)
Trastuzumab Emtansine
Ovarian Carcinoma
OHSU Knight Cancer InstituteP2B (56)
Trastuzumab Emtansine
Prostate Carcinoma
OHSU Knight Cancer InstituteP2B (56)
Tucatinib
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer InstituteP2B (56)
Tucatinib
Gastric Cancer
Seagen, a wholly owned subsidiary of PfizerP2B (56)
Tucidinostat
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Peking Union Medical College HospitalP2B (56)
Vemurafenib
Breast Cancer
OHSU Knight Cancer InstituteP2B (56)
Vemurafenib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2B (56)
Venetoclax
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
First Affiliated Hospital of Zhejiang UniversityP2B (56)
Venetoclax
CD4+/CD56+ Hematodermic Neoplasm
French Innovative Leukemia OrganisationP2B (56)
Venetoclax
Hematopoietic And Lymphoid Cell Neoplasm
University of Alabama at BirminghamP2B (56)
(+)-Vincristine
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research NetworkP2B (56)
(+)-Vincristine
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer CenterP2B (56)
(+)-Vincristine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Andrew E. Place, MDP2B (56)
(+)-Vincristine
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP2B (56)
Vorinostat
Myelodysplastic Syndrome With Ring Sideroblasts
National Cancer Institute (NCI)P2B (56)
Vorinostat
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2B (56)
Vorinostat
Myelodysplastic Syndrome With Single Lineage Dysplasia
National Cancer Institute (NCI)P2B (56)
Vorolanib
Neoplasm
Li-kun ChenP2B (56)
Yb-1
Her2-Receptor Negative Breast Cancer
University of WashingtonP2B (56)
yy-20394
B-Cell Non-Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd.P2B (56)
Showing 2551 to 2575 of 13,150 assets
PreviousPage 103 of 526Next